SINTX Technologies

SINTX Technologies Financial Leverage

The Financial Leverage (Equity Multiplier) of SINTX Technologies (SINT) as of Oct 26, 2026 is 3.25. In the previous year, Financial Leverage (Equity Multiplier) was 2.42 — a change of 34.26% (higher).

Financial Leverage

3.25

YoY

34.26%

Last updated:

Financial Leverage (Equity Multiplier) of SINTX Technologies is 2025 3.25 . Financial Leverage (Equity Multiplier) of SINTX Technologies was 2024 2.42 . It decreases by 34.26% higher compared to the previous year.

The SINTX Technologies Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.37 USD
Jan 1, 2019
1.76 USD
Jan 1, 2020
1.18 USD
Jan 1, 2021
1.27 USD
Jan 1, 2022
2.77 USD
Jan 1, 2023
1.75 USD
Jan 1, 2024
2.42 USD
Jan 1, 2025
3.25 USD
The SINTX Technologies Financial Leverage history
YEARFinancial LeverageYoY
3.25+34.26%
2.42+38.01%
1.75-36.66%
2.77+117.71%
1.27+7.64%
1.18-32.90%
1.76+28.25%
1.37-49.04%
2.69+47.25%
1.83-28.67%
2.56-62.82%
6.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SINTX Technologies Stock analysis

What does SINTX Technologies do? SINTX Technologies, Inc. generates revenue by manufacturing and selling silicon nitride-based orthopedic medical devices. The company focuses on vertically integrated production of silicon nitride ceramic technology for hip and knee arthroplasty components, including solid, porous, composite, and coated forms. Its primary customers are surgeons and hospitals in the United States, Europe, and South America, who purchase these wear- and corrosion-resistant implant components for total hip and knee replacement procedures. The firm markets its products directly to healthcare providers through its established distribution channels in target markets. The company's revenue stream is derived from the sale of silicon nitride ceramic technology platforms used in medical devices, with a specific emphasis on orthopedic applications. By developing and producing implant components that incorporate silicon nitride, SINTX addresses the need for durable, high-performance materials in joint replacement surgeries. This approach allows the company to target the growing market for advanced orthopedic solutions in key regions. SINTX Technologies, Inc. operates as a commercial biomaterial company specializing in silicon nitride ceramic technology. Its product portfolio includes components for total hip and knee replacement systems, which are sold to healthcare institutions globally. The firm's vertically integrated manufacturing model ensures control over the production of silicon nitride materials, enabling consistent quality and innovation in its medical device offerings. SINTX Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SINTX Technologies stock

Financial Leverage (Equity Multiplier) of SINTX Technologies is 3.25 in 2025.

Financial Leverage (Equity Multiplier) of SINTX Technologies changed from 2.42 to 3.25, representing a 34.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) SINTX Technologies since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s SINTX Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — SINTX Technologies

All Key Metrics — SINTX Technologies